ArticleProceedings of the National Academy of Sciences of the United States of America2026
The policy construction of illegal markets: Exploring variation, success, failure, and unintended consequences.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A budding science of illegal markets.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Illegal markets: An important domain for applied science.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Illegal markets, broadly defined to include markets where only specific transactions are illegal, are the consequence of policy, either a prohibition or highly restrictive regulation. They are generated by a variety of concerns, some moral, some pragmatic. They are often tied to legal markets, complicating the policy process. These markets are ubiquitous, rarely well controlled and little studied as markets. This article examines variations in illegality from the case studies in this Special Feature and synthesizes what can be learned about the success and failure of different approaches to controlling these markets. Control is often weak because powerful legal interests are opposed to tight regulation and, especially in markets with large underlying demand, rarely leads to substantial reductions in the targeted activity, unless draconian methods are used. As demonstrated by drug markets, tough enforcement can have large adverse collateral consequences. The paper concludes by suggesting that an extension of the harm reduction framework developed specifically for drug policy can be applied usefully to making policy choices in controlling other illegal markets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.